Chronic treatment with the monoamine oxidase inhibitor phenelzine increases hypothalamic-pituitary-adrenocortical activity in male C57BL/6 mice: Relevance to atypical depression

被引:23
作者
Kier, A [1 ]
Han, J [1 ]
Jacobson, L [1 ]
机构
[1] Albany Med Coll, Ctr Neuropharmacol & Neurosci, Albany, NY 12208 USA
关键词
D O I
10.1210/en.2004-0650
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Atypical depression has been linked to low hypothalamic-pituitary-adrenocortical axis activity and exhibits physical and affective symptoms resembling those of glucocorticoid deficiency. Because atypical depression has also been defined by preferential responsiveness to monoamine oxidase inhibitors (MAO-I), we hypothesized that MAO-I reverse these abnormalities by interfering with glucocorticoid feedback and increasing hypothalamic-pituitary-adrenocortical activity. To test this hypothesis, we measured plasma hormones and ACTH secretagogue gene expression in male C57BL/6 mice treated chronically with saline vehicle or phenelzine, a representative MAO-I. Changes in glucocorticoid feedback were evaluated using adrenalectomized (ADX) mice with and without corticosterone replacement. Antidepressant efficacy was confirmed by decreased immobility during forced swim testing. Phenelzine significantly increased circadian nadir and postrestraint plasma corticosterone levels in sham-operated mice, an effect that correlated with increased adrenocortical sensitivity to ACTH. Phenelzine increased circadian nadir, but not poststress ACTH in ADX mice, suggesting that phenelzine augmented corticosterone secretion in sham-operated mice by increasing stimulation and decreasing feedback inhibition of hypothalamic-pituitary activity. Consistent with the latter possibility, phenelzine significantly increased plasma ACTH and paraventricular hypothalamus CRH mRNA in ADX, corticosterone-replaced mice. Phenelzine did not increase paraventricular hypothalamus CRH or vasopressin mRNA in ADX mice lacking corticosterone replacement. We conclude that chronic phenelzine treatment induces sustained increases in glucocorticoids by impairing glucocorticoid feedback, increasing adrenocortical responsiveness to ACTH, and increasing glucocorticoid-independent stimulation of hypothalamic-pituitary activity. The resulting drive for adrenocortical activity could account for the ability of MAO-I to reverse endocrine and psychiatric symptoms of glucocorticoid deficiency in atypical depression.
引用
收藏
页码:1338 / 1347
页数:10
相关论文
共 61 条
[21]   Functional innervation of the adrenal cortex by the splanchnic nerve [J].
Engeland, WC .
HORMONE AND METABOLIC RESEARCH, 1998, 30 (6-7) :311-314
[22]   Low cerebrospinal fluid corticotropin-releasing hormone concentrations in eucortisolemic depression [J].
Geracioti, TD ;
Loosen, PT ;
Orth, DN .
BIOLOGICAL PSYCHIATRY, 1997, 42 (03) :165-174
[23]   Divergent endocrine abnormalities in melancholic and atypical depression: clinical and pathophysiologic implications [J].
Gold, PW ;
Gabry, KE ;
Yasuda, MR ;
Chrousos, GP .
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2002, 31 (01) :37-+
[24]   The effect of chronic administration of antidepressants on the circadian pattern of corticosterone in the rat [J].
Gómez, F ;
Graugés, P ;
Martin, M ;
Armario, A .
PSYCHOPHARMACOLOGY, 1998, 140 (02) :127-134
[25]   THE EFFECTS OF CORTISOL INFUSION UPON HORMONE-SECRETION FROM THE ANTERIOR-PITUITARY AND SUBJECTIVE MOOD IN DEPRESSIVE-ILLNESS AND IN CONTROLS [J].
GOODWIN, GM ;
MUIR, WJ ;
SECKL, JR ;
BENNIE, J ;
CARROLL, S ;
DICK, H ;
FINK, G .
JOURNAL OF AFFECTIVE DISORDERS, 1992, 26 (02) :73-84
[26]   Behavioral effects of phenelzine in an experimental model for screening anxiolytic and anti-panic drugs: correlation with changes in monoamine-oxidase activity and monoamine levels [J].
Griebel, G ;
Curet, O ;
Perrault, G ;
Sanger, DJ .
NEUROPHARMACOLOGY, 1998, 37 (07) :927-935
[27]   The combined DEX-CRH test in treatment course and long-term outcome of major depression [J].
Hatzinger, M ;
Hemmeter, UM ;
Baumann, K ;
Brand, S ;
Holsboer-Trachsler, E .
JOURNAL OF PSYCHIATRIC RESEARCH, 2002, 36 (05) :287-297
[28]   Central mechanisms of stress integration: hierarchical circuitry controlling hypothalamo-pituitary-adrenocortical responsiveness [J].
Herman, JP ;
Figueiredo, H ;
Mueller, NK ;
Ulrich-Lai, Y ;
Ostrander, MM ;
Choi, DC ;
Cullinan, WE .
FRONTIERS IN NEUROENDOCRINOLOGY, 2003, 24 (03) :151-180
[29]   THE COMBINED DEXAMETHASONE CRH TEST - A REFINED LABORATORY TEST FOR PSYCHIATRIC-DISORDERS [J].
HEUSER, I ;
YASSOURIDIS, A ;
HOLSBOER, F .
JOURNAL OF PSYCHIATRIC RESEARCH, 1994, 28 (04) :341-356
[30]   STRESS-INDUCED ACTIVATION OF NEURONAL-ACTIVITY AND CORTICOTROPIN-RELEASING FACTOR GENE-EXPRESSION IN THE PARAVENTRICULAR NUCLEUS IS MODULATED BY GLUCOCORTICOIDS IN RATS [J].
IMAKI, T ;
WANG, XQ ;
SHIBASAKI, T ;
YAMADA, K ;
HARADA, S ;
CHIKADA, N ;
NARUSE, M ;
DEMURA, H .
JOURNAL OF CLINICAL INVESTIGATION, 1995, 96 (01) :231-238